What does APOTEEK ROGGEN do?

APOTEEK ROGGEN is a pharmacy in Dilbeek. Private Limited, started on 20 October 1986, 1 establishment.

What is the address of APOTEEK ROGGEN?

The registered office of APOTEEK ROGGEN is located at Brusselstraat 322, 1702 Dilbeek.

Is APOTEEK ROGGEN still active?

Yes. According to the CBE (31 October 2026) APOTEEK ROGGEN is active, legal situation “Normale toestand”, started on 20 October 1986.

Is APOTEEK ROGGEN registered on Peppol?

Yes, APOTEEK ROGGEN is registered on the Peppol network with ID 0208:0429614285.

What is the enterprise number of APOTEEK ROGGEN?

The enterprise number of APOTEEK ROGGEN is BE0429614285.

When was APOTEEK ROGGEN founded?

APOTEEK ROGGEN was founded on 20 October 1986.

Who are the directors of APOTEEK ROGGEN?

According to the 2025 annual accounts, the directors of APOTEEK ROGGEN are: Griet Vande Maele, Barcas bvba, Bart De Vlamynck.

Is APOTEEK ROGGEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 October 1986; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did APOTEEK ROGGEN make in 2025?

APOTEEK ROGGEN posted a profit after taxes of € 9,128 in financial year 2025.

What is the revenue of APOTEEK ROGGEN?

As a small company, APOTEEK ROGGEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 71,877.

Does APOTEEK ROGGEN have a website?

Yes, APOTEEK ROGGEN has a website at apotheekgrootbijgaarden.be.

APOTEEK ROGGEN (Private Limited) - Dilbeek - BE0429614285

Dossier APOTEEK ROGGEN, printed on 31 October 2026 from databakkes.be/en/0429614285/apoteek-roggen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTEEK ROGGEN from Dilbeek, company number BE0429614285, closed financial year 2025 with a result of € 9,128 after tax. For that financial year APOTEEK ROGGEN recorded a gross margin of € 71,877 and equity of € 572,143. Compared with financial year 2024, the result moved from € 73,276 to € 9,128. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 24, 2026.

What it is worth Healthy

€ 572,143

▼ 5% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 9,128

▼ 88% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 338,574

▲ 50% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 40,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Wage cost

€ 25,638

▼ 60% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 51,115

▲ 255% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 276,770

▲ € 213,657 vs 2024

€ 53,824 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 155,357

▲ 2% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 623

▼ 94% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 210,649 Gross margin 2022: € 210,649 First fiscal year in the series	€ 162,178 Gross margin 2023: € 162,178 ▼ 23% vs 2022 (€ 210,649) Unfavourable step	€ 193,664 Gross margin 2024: € 193,664 ▲ 19% vs 2023 (€ 162,178) Favourable step	€ 71,877 Gross margin 2025: € 71,877 ▼ 63% vs 2024 (€ 193,664) Unfavourable step	▼ 63%
Profit after taxes	€ 88,401 Profit after taxes 2022: € 88,401 First fiscal year in the series	€ 62,225 Profit after taxes 2023: € 62,225 ▼ 30% vs 2022 (€ 88,401) Unfavourable step	€ 73,276 Profit after taxes 2024: € 73,276 ▲ 18% vs 2023 (€ 62,225) Favourable step	€ 9,128 Profit after taxes 2025: € 9,128 ▼ 88% vs 2024 (€ 73,276) Unfavourable step	▼ 88%
Equity	€ 567,513 Equity 2022: € 567,513 First fiscal year in the series	€ 529,738 Equity 2023: € 529,738 ▼ 7% vs 2022 (€ 567,513) Unfavourable step	€ 603,015 Equity 2024: € 603,015 ▲ 14% vs 2023 (€ 529,738) Favourable step	€ 572,143 Equity 2025: € 572,143 ▼ 5% vs 2024 (€ 603,015) Unfavourable step	▼ 5%
Total debts	€ 336,427 Total debts 2022: € 336,427 First fiscal year in the series	€ 338,816 Total debts 2023: € 338,816 ▲ 1% vs 2022 (€ 336,427) Unfavourable step	€ 229,119 Total debts 2024: € 229,119 ▼ 32% vs 2023 (€ 338,816) Favourable step	€ 473,023 Total debts 2025: € 473,023 ▲ 106% vs 2024 (€ 229,119) Unfavourable step	▲ 106%
Cash	€ 344,273 Cash 2022: € 344,273 First fiscal year in the series	€ 328,719 Cash 2023: € 328,719 ▼ 5% vs 2022 (€ 344,273) Unfavourable step	€ 226,123 Cash 2024: € 226,123 ▼ 31% vs 2023 (€ 328,719) Unfavourable step	€ 338,574 Cash 2025: € 338,574 ▲ 50% vs 2024 (€ 226,123) Favourable step	▲ 50%
Retained profit	€ 548,921 Retained profit 2022: € 548,921 First fiscal year in the series	€ 511,146 Retained profit 2023: € 511,146 ▼ 7% vs 2022 (€ 548,921) Unfavourable step	€ 584,423 Retained profit 2024: € 584,423 ▲ 14% vs 2023 (€ 511,146) Favourable step	€ 553,551 Retained profit 2025: € 553,551 ▼ 5% vs 2024 (€ 584,423) Unfavourable step	▼ 5%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 100,000 Dividend 2023: € 100,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 100,000) Unchanged	€ 40,000 Dividend 2025: € 40,000 Unchanged (€ 0) Unchanged
Bank debt	€ 121,178 Bank debt 2022: € 121,178 First fiscal year in the series	€ 93,159 Bank debt 2023: € 93,159 ▼ 23% vs 2022 (€ 121,178) Favourable step	€ 63,114 Bank debt 2024: € 63,114 ▼ 32% vs 2023 (€ 93,159) Favourable step	€ 276,770 Bank debt 2025: € 276,770 ▲ € 213,657 vs 2024 (€ 63,114) Unfavourable step	▲ € 213,657
Balance sheet total	€ 903,940 Balance sheet total 2022: € 903,940 First fiscal year in the series	€ 868,554 Balance sheet total 2023: € 868,554 ▼ 4% vs 2022 (€ 903,940) Unchanged	€ 832,134 Balance sheet total 2024: € 832,134 ▼ 4% vs 2023 (€ 868,554) Unchanged	€ 1,045,166 Balance sheet total 2025: € 1,045,166 ▲ 26% vs 2024 (€ 832,134) Unchanged	▲ 26%
Employees (FTE)	0.8 Employees (FTE) 2022: 0.8 First fiscal year in the series	0.9 Employees (FTE) 2023: 0.9 ▲ 0.1 vs 2022 (0.8) Unchanged	-	-

Key figures of APOTEEK ROGGEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTEEK ROGGEN?

What happened at APOTEEK ROGGEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 24, 2026 New annual accounts for financial year 2025: profit of € 9,128 (▼ 88% vs 2024). filed late Source: NBB ↗
2021 Bart De Vlamynck became a director. NBB
2013 Griet Vande Maele became a director. NBB
Nov 13, 1986 New establishment in Dilbeek. KBO
Oct 20, 1986 Start of the company according to the CBE. KBO

In short

From € 88,401 profit in 2022 to € 9,128 profit in 2025.

Paid € 79,846 in corporate taxes since 2022.

Best year ever: 2022, with € 88,401 profit.

Paid out € 140,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

BARCAS 99.7%

The stake of BARCAS comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTEEK ROGGEN

Behind APOTEEK ROGGEN are Griet Vande Maele, Barcas bvba and Bart De Vlamynck. The shares are held by BARCAS (99.7%).

Directors

According to the 2025 annual accounts

Griet Vande Maele

Director

since 2013

Barcas bvba

Director

Bart De Vlamynck

Director

Also active at: ROGGEN APO

since 2021

Shareholders

BARCAS

99.7%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Brusselstraat 322

1702 Dilbeek

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

BARCAS same network

€ 146,889 gross margin · 2025

ROGGEN APO same network

€ 6,523 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS apotheekgrootbijgaarden.be

Technologies

BootstrapChart.jsCloudflare CDNDiviElementorFacebook PixelFont AwesomeGoogle FontsOwl CarouselPHPSwiperWP RocketWPMLWooCommerceWordPressYoast SEOjQueryjQuery UIlazysizesreCAPTCHA

Hosting & Email

Email provider

Self-hosted

Hosting

CLOUDFLARENET - Cloudflare, Inc., US

DNS

Cloudflare DNS

Website info

HTTPS Ja

Languages FR, NL

Features

Webshop Blog Ads Contact page

Security

✓ HTTPS

✓ SPF

✗ DMARC

Network

✓ IPv6

✓ Load balancing

Details

Company number

0429.614.285

VAT number

BE 0429.614.285

Registered office

Brusselstraat 322, 1702 Dilbeek

Names & denominations

APOTEEK ROGGEN

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

20 October 1986

Peppol

Active · Active since 12 Dec 2025

Contact

apotheekgrootbijgaarden.be

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTEEK ROGGEN

Financials

What happened to APOTEEK ROGGEN?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Website

Technologies

Hosting & Email

Website info

Features

Security

Network

Details

Frequently asked questions